Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery
The goal of the trial is to test the usability, feasibility and acceptability of an unsupervised, appbased yoga program for participants undergoing thoracic RT and their caregivers.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Sep 25, 2026 · Source: ClinicalTrials.gov
The study is currently accepting participants.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- M.D. Anderson Cancer Center
- Interventions being studied
- Behavioral: Thinking out Loud Session
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
1. Be diagnosed with a non-small cell lung cancer or esophageal cancer and going to receive at least 24 fractions thoracic RT 2. Have an ECOG performance status of \<2 3. Have a family caregiver (e.g., spouse, sibling, adult child) willing to participate Both patient and caregiver must meet all the following criteria: 1. Be \>18 years old 2. Be able to read and speak English 3. Be able to provide informed consent 4. Have regular (self-defined) access to Wi-Fi/High speed internet access
1. Experiences cognitive deficits that would impede the completion of self-report instruments as deemed by their attending oncologist per medical notes and/or patient not being oriented to time, place and person. 2. Regularly (self-defined) participants in a yoga program in the year prior to diagnosis Participants who participated in part 1 are ineligible to participate in part 2 of this protocol.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- The University of Texas M. D. Anderson Cancer CenterHouston, Texas
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 25, 2026. Always confirm current availability with the study team.